Does Wegovy affect cellulite? What weight loss actually does to skin

You've started losing weight and the cellulite hasn't gone, here's why

Cellulite isn't simply a fat problem, which is why reducing body fat doesn't always make it disappear. The dimpled effect comes from the way fat cells sit in compartments formed by connective tissue strands called fibrous septae. In women, those strands tend to run vertically, allowing fat to bulge upward toward the skin's surface. Hormones, genetics, circulation and skin thickness all play a role too. This is why people at a perfectly healthy weight can have pronounced cellulite, while others with higher body fat have very little.

When you lose weight, the fat cells in those compartments do shrink. For some people that reduces the bulging effect and the skin looks smoother. For others, particularly if skin elasticity has reduced with age or the loss happens quickly, the texture stays similar or the skin looks slightly looser. Neither outcome means something has gone wrong, it just reflects how individual the relationship between fat and skin really is.

A common misconception worth naming gently: many people expect a medicine that produces meaningful weight loss to also resolve cellulite. That expectation is understandable, but cellulite is a structural feature of the skin, not a measure of how much fat you're carrying or how well a treatment is working. Wegovy's clinical trials measured body weight and cardiometabolic markers, not skin texture. The two things are simply different questions.

What the Wegovy trial evidence covers, and what it doesn't say about skin

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks and found an average body-weight reduction of around 15% with the 2.4mg semaglutide dose alongside lifestyle changes. That degree of weight loss over more than a year is meaningful, it gives skin and connective tissue more time to adapt than a crash diet would. But the trial measured weight, blood pressure, waist circumference and quality of life. Skin appearance wasn't an endpoint, and cellulite wasn't assessed.

The same applies to higher-dose options. The MHRA approved a dedicated 7.2mg Wegovy pen in April 2026, with trial data showing around 20.7% average weight loss over 72 weeks. That's a substantial reduction in fat mass for many people. Yet even at that level of loss, whether cellulite changes depends on factors no medicine can fully control: age, genetics, where your body preferentially stores and releases fat, and how your skin responds to the change.

If you've read that a particular injection "melts" cellulite, that claim isn't supported by clinical evidence. The NHS patient information for semaglutide covers the medicine's licensed uses and known effects, skin texture isn't among them. For a balanced overview of how semaglutide works and what it's approved for, the semaglutide treatment overview sets this out clearly.

How rate of weight loss may matter for skin texture

One thing that does seem to make a difference is pace. Gradual, sustained fat loss gives collagen and elastin fibres time to remodel. When weight comes off quickly, that remodelling process can lag behind, leaving skin looking looser or, in some cases, making the underlying structure of cellulite more visible temporarily as the fat padding reduces.

Wegovy's titration schedule, moving up from lower doses over several months, tends to produce loss at a rate that is relatively measured compared with very low-calorie crash approaches. That's worth knowing. It's also one reason that staying on treatment and not rushing the dose increase matters, though your prescriber decides the titration pace based on how you're tolerating the medicine, not on cosmetic goals.

Protein intake, hydration and resistance exercise alongside treatment are all worth discussing with your clinical team. Preserving muscle mass during weight loss supports skin structure. The weight loss treatment overview covers the lifestyle factors that tend to matter most alongside any prescription medicine. You might also want to look at the cost of Wegovy if you're planning ahead, or read about injection site reactions if anything feels uncomfortable after dosing.

What this means in practice, and when to ask your prescriber

If improving skin texture is one of your goals, it's worth having that conversation openly at your consultation rather than assuming the medicine will address it. A prescriber can give you a realistic picture based on your age, starting weight, and medical history, and can flag whether the rate of loss or anything else in your plan might affect how your skin responds.

Wegovy is a prescription medicine for weight management. It works by activating GLP-1 receptors in the brain and gut to reduce appetite and slow gastric emptying, producing genuine, clinically meaningful weight loss for many people. For a fuller explanation of how the medicine works and what to expect, the Wegovy treatment page is a good starting point, and if you want to explore the full range of information available, our semaglutide website brings it all together in one place. Our clinical team, led by our clinical director, reviews every consultation personally, a real prescriber, not a queue. Skin changes are absolutely the kind of thing to raise in your answers. If you have questions before starting, our FAQs or the contact page are both there. When you're ready, start your free consultation and put it all in front of someone who can actually answer it for your situation, and if you're looking specifically at the starting dose, the Wegovy 1mg dose page covers what to expect in those early weeks.